BRIEF-Blank Check Company Drugs Made In America Acquisition II Corp Sees IPO Of $500 Million

BRIEF-Blank Check Company Drugs Made In America Acquisition II Corp Sees IPO Of $500 Million - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Blank Check Company Drugs Made In America Acquisition II Corp Sees IPO Of $500 Million - SEC Filing

Jul 21, 2025 3:19 AM

July 21 (Reuters) -

* BLANK CHECK COMPANY DRUGS MADE IN AMERICA ACQUISITION II

CORP

SEES IPO OF $500 MILLION - SEC FILING

* DRUGS MADE IN AMERICA ACQUISITION II CORP INTENDS TO LIST

UNITS

ON THE NASDAQ UNDER SYMBOL "DMIIU"- SEC FILING

* DRUGS MADE IN AMERICA ACQUISITION II CORP: CANTOR IS

UNDERWRITER

TO IPO - SEC FILING

Source text:

Further company coverage: [ ]

Previous page： Form 8.3 Next page： Form 8.3

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Form 8.3

Nov 4, 2025

BOSTON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund) (b) Owner or controller of interests...

BOSTON--(BUSINESS WIRE)-- Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity...

Packaging firm TriMas to sell aerospace arm for $1.45 billion under Barington pressure

Nov 4, 2025

* Investment firm Tinicum to buy TriMas Aerospace * Activist Barington Capital had sought segment sale * Aerospace segment contributed 38% of net sales * Blackstone funds to be minority investor after all-cash deal (Adds details throughout) Nov 4 (Reuters) - TriMas Corp ( TRS ) is selling its aerospace segment to an affiliate of investment firm Tinicum for $1.45...